Prevention of Pneumocystis carinii pneumonia.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000336:Aerosols; D003622:Dapsone / Q000627:therapeutic use; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*; D011739:Pyrimethamine / Q000627:therapeutic use; D012008:Recurrence; D013413:Sulfadoxine / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000336:Aerosols; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D013413:Sulfadoxine; D003622:Dapsone; D014295:Trimethoprim; D013420:Sulfamethoxazole; D011739:Pyrimethamine